![AMCP Format 5.0 Image](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/AMCP_Format5_800x650.jpg.webp?itok=-IzLV6bO)
Featured
![AMCP Format 5.0 Image](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/AMCP_Format5_800x650.jpg.webp?itok=-IzLV6bO)
![AMCP Engagement Framework For Payers And Patient Organizations - Overview](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/AMCP-Engagement-Framework-For-Payers-And-Patient-Organizations-cover.jpg.webp?itok=cNo15Mje)
![Patient Input and Payer Decision-Making Forum](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/PF-DEC2023_ProgramGuide_patient-payer0decision-making-thumb.png.webp?itok=jwwVnoCD)
![AMCP Health Disparities White Paper - Cover](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/HD-Landscape-Assessment-cover.jpg.webp?itok=85gXXi10)
![AMCP Disabilities Health Action Brief](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/DISABILITIES-Health-Action-Brief-Sept-2023-thumb.png.webp?itok=cTGBmnKC)
![Health Equity Science & Innovation Webinar Sandoz](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/Health-equity-SI-webinar-sandoz-thumb.jpg.webp?itok=yYGDhuxs)
![AMCP Geographic Inequality Health Equity Action Brief](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/AMCP-Geographic-Inequality-Health-Equity-Action-Brief-Jan-2024-thumb.png.webp?itok=xkJC5D0e)
From the AMCP Policy Digest, AMCP's policies regarding dispensing issues.
Sponsored webinar that discussed the urgency needed to diagnose lupus nephritis as early as possible, and the multidisciplinary care needed in patient management to prevent irreversible kidney damage and progression to end-stage renal disease (ESRD).
Sponsored webinar that discussed the urgency needed to diagnose lupus nephritis as early as possible, and the multidisciplinary care needed in patient management to prevent irreversible kidney damage and progression to end-stage renal disease (ESRD).
![JMCP Cover Image](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/JMCPCover2020.png.webp?itok=QvhRe9NY)
Orthopedic surgery can be performed in hospital outpatient departments (HOPDs) and ambulatory surgical centers (ASCs), as well as in traditional inpatient venues. Patients who undergo orthopedic surgery may be prescribed opioids for the management of postsurgical pain. However, the association between surgery venue, postsurgical opioid use, and health care costs remains unclear.
![JMCP Cover Image](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/JMCPCover2020.png.webp?itok=QvhRe9NY)
More than 30% of Medicare beneficiaries and 40% of patients dually eligible for Medicare and Medicaid use opioids. With an estimated 8%-12% of patients developing an opioid use disorder (OUD) after initiating opioids, opioid misuse is a significant public health challenge, especially among high-risk Medicare populations. Medication-assisted treatment (MAT) is the use of medications for the treatment of OUD and to prevent relapse to opioid use. MAT is the most effective treatment for OUD. There are a variety of barriers to MAT therapy that may delay access to treatment.
Sponsored webinar that provided insights into the "hidden" burden of Systemic Lupus Erythematosus (SLE): a multisystemic autoimmune disease.
![People taking medication](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/Prescription%20Drugs_0.jpg.webp?itok=whZHsWe0)
AMCP supports regulatory and legislative provisions relating to opioid management that ensure appropriate patient access and treatment of uncontrolled pain, while limiting abuse and diversion of opioids and opioid potentiators. .
From the AMCP Policy Digest, AMCP's policies regarding drug pricing.
From the AMCP Policy Digest, AMCP's policies regarding health insurance marketplaces.
From the AMCP Policy Digest, AMCP's policies regarding Medicare Part D.
![JMCP Cover Image](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/JMCPCover2020.png.webp?itok=QvhRe9NY)
Obesity has become a major public health crisis in the United States. Research to date has consistently demonstrated a correlation between obesity and higher medical costs for a variety of U.S. subpopulations and specific categories of care. However, by examining associations rather than causal effects, previous studies likely underestimated the effect of obesity on medical expenditures.
Presentation developed for AMCP in February 2015